Global Artificial Intelligence Drug R&D Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 50399
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Services
Buy @ $3500

The Artificial Intelligence Drug R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Artificial Intelligence Drug R&D size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Artificial Intelligence Drug R&D market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

AI Platfrom

Analytics Service

Market segment by Application, can be divided into

Drug Discovery

Precision Medicine

Market segment by players, this report covers

IBM Watson

BioXel

Insilico Medicine

Gatehouse Bio

Google DeepMind

Genpact Cora

Cyclica Inc

QuantumBlack

Nq Medical

Phenomic AI

Palantir Technologies

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Artificial Intelligence Drug R&D

1.2 Classification of Artificial Intelligence Drug R&D by Type

1.2.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Type in 2020

1.2.3 AI Platfrom

1.2.4 Analytics Service

1.3 Global Artificial Intelligence Drug R&D Market by Application

1.3.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Drug Discovery

1.3.3 Precision Medicine

1.4 Global Artificial Intelligence Drug R&D Market Size & Forecast

1.5 Global Artificial Intelligence Drug R&D Market Size and Forecast by Region

1.5.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Artificial Intelligence Drug R&D Market Size by Region, (2016-2021)

1.5.3 North America Artificial Intelligence Drug R&D Market Size and Prospect (2016-2026)

1.5.4 Europe Artificial Intelligence Drug R&D Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Artificial Intelligence Drug R&D Market Size and Prospect (2016-2026)

1.5.6 South America Artificial Intelligence Drug R&D Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Artificial Intelligence Drug R&D Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Artificial Intelligence Drug R&D Market Drivers

1.6.2 Artificial Intelligence Drug R&D Market Restraints

1.6.3 Artificial Intelligence Drug R&D Trends Analysis

2 Company Profiles

2.1 IBM Watson

2.1.1 IBM Watson Details

2.1.2 IBM Watson Major Business

2.1.3 IBM Watson Artificial Intelligence Drug R&D Product and Solutions

2.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 IBM Watson Recent Developments and Future Plans

2.2 BioXel

2.2.1 BioXel Details

2.2.2 BioXel Major Business

2.2.3 BioXel Artificial Intelligence Drug R&D Product and Solutions

2.2.4 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 BioXel Recent Developments and Future Plans

2.3 Insilico Medicine

2.3.1 Insilico Medicine Details

2.3.2 Insilico Medicine Major Business

2.3.3 Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions

2.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Insilico Medicine Recent Developments and Future Plans

2.4 Gatehouse Bio

2.4.1 Gatehouse Bio Details

2.4.2 Gatehouse Bio Major Business

2.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions

2.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Gatehouse Bio Recent Developments and Future Plans

2.5 Google DeepMind

2.5.1 Google DeepMind Details

2.5.2 Google DeepMind Major Business

2.5.3 Google DeepMind Artificial Intelligence Drug R&D Product and Solutions

2.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Google DeepMind Recent Developments and Future Plans

2.6 Genpact Cora

2.6.1 Genpact Cora Details

2.6.2 Genpact Cora Major Business

2.6.3 Genpact Cora Artificial Intelligence Drug R&D Product and Solutions

2.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Genpact Cora Recent Developments and Future Plans

2.7 Cyclica Inc

2.7.1 Cyclica Inc Details

2.7.2 Cyclica Inc Major Business

2.7.3 Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions

2.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Cyclica Inc Recent Developments and Future Plans

2.8 QuantumBlack

2.8.1 QuantumBlack Details

2.8.2 QuantumBlack Major Business

2.8.3 QuantumBlack Artificial Intelligence Drug R&D Product and Solutions

2.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 QuantumBlack Recent Developments and Future Plans

2.9 Nq Medical

2.9.1 Nq Medical Details

2.9.2 Nq Medical Major Business

2.9.3 Nq Medical Artificial Intelligence Drug R&D Product and Solutions

2.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Nq Medical Recent Developments and Future Plans

2.10 Phenomic AI

2.10.1 Phenomic AI Details

2.10.2 Phenomic AI Major Business

2.10.3 Phenomic AI Artificial Intelligence Drug R&D Product and Solutions

2.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Phenomic AI Recent Developments and Future Plans

2.11 Palantir Technologies

2.11.1 Palantir Technologies Details

2.11.2 Palantir Technologies Major Business

2.11.3 Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions

2.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Palantir Technologies Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Artificial Intelligence Drug R&D Players Market Share

3.2.2 Top 10 Artificial Intelligence Drug R&D Players Market Share

3.2.3 Market Competition Trend

3.3 Artificial Intelligence Drug R&D Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Artificial Intelligence Drug R&D Revenue and Market Share by Type (2016-2021)

4.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2016-2021)

5.2 Artificial Intelligence Drug R&D Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Artificial Intelligence Drug R&D Revenue by Type (2016-2026)

6.2 North America Artificial Intelligence Drug R&D Revenue by Application (2016-2026)

6.3 North America Artificial Intelligence Drug R&D Market Size by Country

6.3.1 North America Artificial Intelligence Drug R&D Revenue by Country (2016-2026)

6.3.2 United States Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

6.3.3 Canada Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

6.3.4 Mexico Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Artificial Intelligence Drug R&D Revenue by Type (2016-2026)

7.2 Europe Artificial Intelligence Drug R&D Revenue by Application (2016-2026)

7.3 Europe Artificial Intelligence Drug R&D Market Size by Country

7.3.1 Europe Artificial Intelligence Drug R&D Revenue by Country (2016-2026)

7.3.2 Germany Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

7.3.3 France Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

7.3.5 Russia Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

7.3.6 Italy Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Artificial Intelligence Drug R&D Revenue by Type (2016-2026)

8.2 Asia-Pacific Artificial Intelligence Drug R&D Revenue by Application (2016-2026)

8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region

8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Revenue by Region (2016-2026)

8.3.2 China Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8.3.3 Japan Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8.3.4 South Korea Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8.3.5 India Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

8.3.7 Australia Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Artificial Intelligence Drug R&D Revenue by Type (2016-2026)

9.2 South America Artificial Intelligence Drug R&D Revenue by Application (2016-2026)

9.3 South America Artificial Intelligence Drug R&D Market Size by Country

9.3.1 South America Artificial Intelligence Drug R&D Revenue by Country (2016-2026)

9.3.2 Brazil Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

9.3.3 Argentina Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Artificial Intelligence Drug R&D Revenue by Type (2016-2026)

10.2 Middle East & Africa Artificial Intelligence Drug R&D Revenue by Application (2016-2026)

10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country

10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Revenue by Country (2016-2026)

10.3.2 Turkey Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

10.3.4 UAE Artificial Intelligence Drug R&D Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Artificial Intelligence Drug R&D Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Artificial Intelligence Drug R&D Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Artificial Intelligence Drug R&D Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Region (2016-2021)

Table 5. Global Artificial Intelligence Drug R&D Revenue Market Share by Region (2021-2026)

Table 6. IBM Watson Corporate Information, Head Office, and Major Competitors

Table 7. IBM Watson Major Business

Table 8. IBM Watson Artificial Intelligence Drug R&D Product and Solutions

Table 9. IBM Watson Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. BioXel Corporate Information, Head Office, and Major Competitors

Table 11. BioXel Major Business

Table 12. BioXel Artificial Intelligence Drug R&D Product and Solutions

Table 13. BioXel Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Insilico Medicine Corporate Information, Head Office, and Major Competitors

Table 15. Insilico Medicine Major Business

Table 16. Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions

Table 17. Insilico Medicine Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Gatehouse Bio Corporate Information, Head Office, and Major Competitors

Table 19. Gatehouse Bio Major Business

Table 20. Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions

Table 21. Gatehouse Bio Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Google DeepMind Corporate Information, Head Office, and Major Competitors

Table 23. Google DeepMind Major Business

Table 24. Google DeepMind Artificial Intelligence Drug R&D Product and Solutions

Table 25. Google DeepMind Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Genpact Cora Corporate Information, Head Office, and Major Competitors

Table 27. Genpact Cora Major Business

Table 28. Genpact Cora Artificial Intelligence Drug R&D Product and Solutions

Table 29. Genpact Cora Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Cyclica Inc Corporate Information, Head Office, and Major Competitors

Table 31. Cyclica Inc Major Business

Table 32. Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions

Table 33. Cyclica Inc Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. QuantumBlack Corporate Information, Head Office, and Major Competitors

Table 35. QuantumBlack Major Business

Table 36. QuantumBlack Artificial Intelligence Drug R&D Product and Solutions

Table 37. QuantumBlack Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Nq Medical Corporate Information, Head Office, and Major Competitors

Table 39. Nq Medical Major Business

Table 40. Nq Medical Artificial Intelligence Drug R&D Product and Solutions

Table 41. Nq Medical Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Phenomic AI Corporate Information, Head Office, and Major Competitors

Table 43. Phenomic AI Major Business

Table 44. Phenomic AI Artificial Intelligence Drug R&D Product and Solutions

Table 45. Phenomic AI Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Palantir Technologies Corporate Information, Head Office, and Major Competitors

Table 47. Palantir Technologies Major Business

Table 48. Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions

Table 49. Palantir Technologies Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Players (2019-2021)

Table 51. Global Artificial Intelligence Drug R&D Revenue Share by Players (2019-2021)

Table 52. Breakdown of Artificial Intelligence Drug R&D by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Artificial Intelligence Drug R&D Players Head Office, Products and Services Provided

Table 54. Artificial Intelligence Drug R&D Mergers & Acquisitions in the Past Five Years

Table 55. Artificial Intelligence Drug R&D New Entrants and Expansion Plans

Table 56. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Type (2016-2021)

Table 57. Global Artificial Intelligence Drug R&D Revenue Share by Type (2016-2021)

Table 58. Global Artificial Intelligence Drug R&D Revenue Forecast by Type (2021-2026)

Table 59. Global Artificial Intelligence Drug R&D Revenue by Application (2016-2021)

Table 60. Global Artificial Intelligence Drug R&D Revenue Forecast by Application (2021-2026)

Table 61. North America Artificial Intelligence Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Artificial Intelligence Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Artificial Intelligence Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Artificial Intelligence Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Artificial Intelligence Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Artificial Intelligence Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Artificial Intelligence Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Artificial Intelligence Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Artificial Intelligence Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Artificial Intelligence Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Artificial Intelligence Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Artificial Intelligence Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Artificial Intelligence Drug R&D Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Artificial Intelligence Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Artificial Intelligence Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Artificial Intelligence Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Artificial Intelligence Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Artificial Intelligence Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Artificial Intelligence Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Artificial Intelligence Drug R&D Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Artificial Intelligence Drug R&D Picture

Figure 2. Global Artificial Intelligence Drug R&D Revenue Market Share by Type in 2020

Figure 3. AI Platfrom

Figure 4. Analytics Service

Figure 5. Artificial Intelligence Drug R&D Revenue Market Share by Application in 2020

Figure 6. Drug Discovery Picture

Figure 7. Precision Medicine Picture

Figure 8. Global Artificial Intelligence Drug R&D Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 9. Global Artificial Intelligence Drug R&D Revenue and Forecast (2016-2026) & (USD Million)

Figure 10. Global Artificial Intelligence Drug R&D Revenue Market Share by Region (2016-2026)

Figure 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Region in 2020

Figure 12. North America Artificial Intelligence Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 13. Europe Artificial Intelligence Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Asia-Pacific Artificial Intelligence Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. South America Artificial Intelligence Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Middle East and Africa Artificial Intelligence Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Artificial Intelligence Drug R&D Market Drivers

Figure 18. Artificial Intelligence Drug R&D Market Restraints

Figure 19. Artificial Intelligence Drug R&D Market Trends

Figure 20. IBM Watson Recent Developments and Future Plans

Figure 21. BioXel Recent Developments and Future Plans

Figure 22. Insilico Medicine Recent Developments and Future Plans

Figure 23. Gatehouse Bio Recent Developments and Future Plans

Figure 24. Google DeepMind Recent Developments and Future Plans

Figure 25. Genpact Cora Recent Developments and Future Plans

Figure 26. Cyclica Inc Recent Developments and Future Plans

Figure 27. QuantumBlack Recent Developments and Future Plans

Figure 28. Nq Medical Recent Developments and Future Plans

Figure 29. Phenomic AI Recent Developments and Future Plans

Figure 30. Palantir Technologies Recent Developments and Future Plans

Figure 31. Global Artificial Intelligence Drug R&D Revenue Share by Players in 2020

Figure 32. Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 33. Global Top 3 Players Artificial Intelligence Drug R&D Revenue Market Share in 2020

Figure 34. Global Top 10 Players Artificial Intelligence Drug R&D Revenue Market Share in 2020

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 36. Global Artificial Intelligence Drug R&D Revenue Share by Type in 2020

Figure 37. Global Artificial Intelligence Drug R&D Market Share Forecast by Type (2021-2026)

Figure 38. Global Artificial Intelligence Drug R&D Revenue Share by Application in 2020

Figure 39. Global Artificial Intelligence Drug R&D Market Share Forecast by Application (2021-2026)

Figure 40. North America Artificial Intelligence Drug R&D Sales Market Share by Type (2016-2026)

Figure 41. North America Artificial Intelligence Drug R&D Sales Market Share by Application (2016-2026)

Figure 42. North America Artificial Intelligence Drug R&D Revenue Market Share by Country (2016-2026)

Figure 43. United States Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Canada Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Mexico Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Europe Artificial Intelligence Drug R&D Sales Market Share by Type (2016-2026)

Figure 47. Europe Artificial Intelligence Drug R&D Sales Market Share by Application (2016-2026)

Figure 48. Europe Artificial Intelligence Drug R&D Revenue Market Share by Country (2016-2026)

Figure 49. Germany Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Artificial Intelligence Drug R&D Sales Market Share by Type (2016-2026)

Figure 55. Asia-Pacific Artificial Intelligence Drug R&D Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Artificial Intelligence Drug R&D Revenue Market Share by Region (2016-2026)

Figure 57. China Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. South Korea Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Artificial Intelligence Drug R&D Sales Market Share by Type (2016-2026)

Figure 64. South America Artificial Intelligence Drug R&D Sales Market Share by Application (2016-2026)

Figure 65. South America Artificial Intelligence Drug R&D Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East and Africa Artificial Intelligence Drug R&D Sales Market Share by Type (2016-2026)

Figure 69. Middle East and Africa Artificial Intelligence Drug R&D Sales Market Share by Application (2016-2026)

Figure 70. Middle East and Africa Artificial Intelligence Drug R&D Revenue Market Share by Country (2016-2026)

Figure 71. Turkey Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Saudi Arabia Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. UAE Artificial Intelligence Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz